Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis
about
Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complexExtensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infectionZika Virus: Medical Countermeasure Development ChallengesNeuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for interventionZika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical TransmissionZika virus productively infects primary human placenta-specific macrophagesZika Fetal Neuropathogenesis: Etiology of a Viral SyndromeVirion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick GetawayTRIM21: a cytosolic Fc receptor with broad antibody isotype specificityImmunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus modelA neutralizing anti-gH/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infectionIgG Fc Receptors Provide an Alternative Infection Route for Murine Gamma-Herpesvirus-68Neonatal Fc receptor and IgG-based therapeuticsThe Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cellsMechanisms and possible controls of the in utero Zika virus infection: Where is the Holy Grail?Microbial Vertical Transmission during Human PregnancyPost-exposure vaccination improves gammaherpesvirus neutralizationPlacental syncytiotrophoblast constitutes a major barrier to vertical transmission of Listeria monocytogenes.Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newbornGlycoprotein L sets the neutralization profile of murid herpesvirus 4.Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infectionRelationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism.Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry.Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes.Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infectionRegulation of immune responses by the neonatal fc receptor and its therapeutic implicationsPlacental Hofbauer cells assemble and sequester HIV-1 in tetraspanin-positive compartments that are accessible to broadly neutralizing antibodies.Transmission of murine cytomegalovirus in breast milk: a model of natural infection in neonatesA high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell typesModeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ cultureEvidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti-IgE/IgE immune complexes.FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.Human cytomegalovirus is protected from inactivation by reversible binding to villous trophoblastsDevelopmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placentaA Homolog Pentameric Complex Dictates Viral Epithelial Tropism, Pathogenicity and Congenital Infection Rate in Guinea Pig CytomegalovirusAntibody evasion by the N terminus of murid herpesvirus-4 glycoprotein B.An "immune barrier" is formed in the placenta by hepatitis B immunoglobulin to protect the fetus from hepatitis B virus infection from the mother.Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular remodeling in an in vivo human placentation model.
P2860
Q21089588-16F4200C-708C-4050-9BC3-7585A6BF7979Q21245045-86C1A08B-233C-4E9D-BC23-925D4EDE8A14Q24261184-4E77F94F-F775-42A7-97B8-CE38D91921F4Q24570124-65943309-76D3-41C0-B1BD-DCE0EF9F0AADQ26252081-133E18BB-4E73-41C6-9E35-4BC535971E7DQ26336601-BFB3134D-18D8-4C32-A2EB-D984B3110220Q26700454-57593FC0-D858-4D77-8EF9-7D7CB71BF98DQ26745798-A234F5DB-4A7D-4DD9-824E-DEDB2C324CCBQ26779753-7C616744-4D5F-4B39-B2AD-CFC857B811B8Q27026924-36C6F2FE-E88E-4B38-AE9D-B2B99A123942Q27329077-3FB1505F-1D41-407B-B3FD-BDC8AAF43678Q27480273-E15F8D4E-1E8D-4598-8A0B-0BD1F16925A6Q28252134-1A85D6F0-D720-4D68-ABBE-38E4FA8DE7D8Q28302792-29D7AE99-E024-425F-A26D-6F6F6CEA5B69Q28733412-4542F136-6F1A-4254-AE77-D561D2AFB4AEQ29994499-FA5B5261-BFCE-40CA-8373-28E2191B1FF4Q33299464-CC14A074-18A7-47A2-979C-9DA5FEB7213DQ33527000-3F26FDFB-F85D-46EB-8736-2F2B69FA21DCQ33835386-92747DC3-DD7D-4634-8AF0-2EE40B6FD907Q33910634-6C9D3788-718C-472E-A49E-0115A758A771Q34086932-336C94C8-7625-48A9-BF21-E98493ADA182Q34098741-693841C9-C277-4CF3-94E9-EA4F9DAD0C8BQ34146728-71CAFCB4-184D-4324-AC60-175613AC49EEQ34541363-9FA8DA1F-707E-4615-967B-60B432B3861DQ34652466-5DF4484C-EFAF-4F38-81DA-0F6FC4955C4BQ34818194-10989CE2-8E7F-49CA-A46C-35D1B7FBB2D6Q35020445-2CC5EBDD-1B12-4B0F-90CD-D53B3058F74CQ35076650-F7BCD93B-82B0-40CC-86C0-9B2163F1D8B0Q35076970-A19BBFD1-17FA-40C6-AD20-96F888FFD5ABQ35599273-770E9838-0BEE-47A8-B537-47952BD90F1BQ35624937-4A6C7E41-B3D9-4FE3-B857-FE71E17EEFD3Q35670904-D73E13F0-BFCE-4071-84DC-43BE5C4EF7BEQ35780389-EE851E72-F951-42DF-BA99-52A14EC74F6CQ35857373-92BBF14C-970B-4533-8A86-5D5F0CE6A8AEQ36069719-FD98A597-466C-4886-BD93-6AA0A56BA207Q36168723-B8616DEC-B4D4-4A56-ADAF-565C3C00CE87Q36255826-07385AAD-1951-4223-9E99-187CBE43259FQ36268583-DF98A783-026D-4CEC-BD19-CE43F6C76845Q36281094-FA8275B4-DAAC-4C6F-A748-B6B74EBBBDBAQ36355613-A56718FF-AF60-48FC-9BAE-F9C6F99EF755
P2860
Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Maternal antibodies enhance or ...... receptor-mediated transcytosis
@ast
Maternal antibodies enhance or ...... receptor-mediated transcytosis
@en
type
label
Maternal antibodies enhance or ...... receptor-mediated transcytosis
@ast
Maternal antibodies enhance or ...... receptor-mediated transcytosis
@en
prefLabel
Maternal antibodies enhance or ...... receptor-mediated transcytosis
@ast
Maternal antibodies enhance or ...... receptor-mediated transcytosis
@en
P2093
P2860
P1476
Maternal antibodies enhance or ...... receptor-mediated transcytosis
@en
P2093
Lenore Pereira
Olga Genbacev
Susan McDonagh
Takako Tabata
P2860
P304
P356
10.2353/AJPATH.2006.050482
P407
P577
2006-04-01T00:00:00Z